Poor speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Long palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Midface retrusion
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Periorbital fullness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Long philtrum
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Thin upper lip vermilion
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Profound intellectual disabilities
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Mild neurosensory hearing impairment
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Shortening of all distal phalanges of the fingers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Clinodactyly of the 2nd toe
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Moderate sensorineural hearing impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absence Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
2-3 toe syndactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Mental Retardation, X-Linked
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.
|
11017088 |
2000 |
Mental Retardation, X-Linked 46
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.
|
11017088 |
2000 |
Mental Retardation, X-Linked 1
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.
|
11017088 |
2000 |
Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.
|
11017088 |
2000 |
Intellectual Disability
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutation screening of 119 patients with nonspecific mental retardation revealed a mutation in the first intron of ARHGEF6 (IVS1-11T-->C) in all affected males in a large Dutch family.
|
11017088 |
2000 |
Mental Retardation, X-Linked
|
0.310 |
Biomarker
|
disease |
BEFREE |
Characterization of ARHGEF6, a guanine nucleotide exchange factor for Rho GTPases and a candidate gene for X-linked mental retardation: mutation screening in Börjeson-Forssman-Lehmann syndrome and MRX27.
|
11337747 |
2001 |
Intellectual Disability
|
0.020 |
Biomarker
|
group |
BEFREE |
Although ARHGEF6 is unlikely to be the gene responsible for either BFLS or MRX27, it remains a prime candidate for nonspecific or syndromic mental retardation linked to Xq26.
|
11337747 |
2001 |
Mental Retardation
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although ARHGEF6 is unlikely to be the gene responsible for either BFLS or MRX27, it remains a prime candidate for nonspecific or syndromic mental retardation linked to Xq26.
|
11337747 |
2001 |
Borjeson-Forssman-Lehmann syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although ARHGEF6 is unlikely to be the gene responsible for either BFLS or MRX27, it remains a prime candidate for nonspecific or syndromic mental retardation linked to Xq26.
|
11337747 |
2001 |
Pulmonary Hypertension
|
0.010 |
AlteredExpression
|
phenotype |
LHGDN |
Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway.
|
15242552 |
2004 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical staining for 3 of the respective gene products, dynein (product of DNCH2), alpha-PIX (product of ARHGEF6), and sorcin (product of SRI) indicated that this technique might be useful for histological grading of glial tumors.
|
16320026 |
2006 |
Glioblastoma Multiforme
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Semi-quantitative RT-PCR experiments with 6 of those genes confirmed higher expression of DNCH2, ARHGEF6, NPM1 and SRI and lower expression of NRGN and TM4SF2 in GBM tumors.
|
16320026 |
2006 |